Articles & Publications :: Hancock Jaffe Laboratories, Inc. (HJLI)

Colombian researchers report positive 24- month results for VenoValve

Colombian researchers report positive 24- month results for VenoValve

Aug 20, 2021

Hancock Jaffe’s Venovalve demonstrates positive outcomes at two-year mark

Hancock Jaffe’s Venovalve demonstrates positive outcomes at two-year mark

Aug 19, 2021

FDA Breakthrough Device Status for Hancock Jaffe VenoValve®

FDA Breakthrough Device Status for Hancock Jaffe VenoValve®

Aug 6, 2021

FDA grants breakthrough device designation to new chronic venous insufficiency device

FDA grants breakthrough device designation to new chronic venous insufficiency device

Aug 6, 2021

FDA Gives Breakthrough Device Designation to VenoValve for CVI

FDA Gives Breakthrough Device Designation to VenoValve for CVI

Aug 5, 2021

FDA Designates VenoValve a Breakthrough Device

FDA Designates VenoValve a Breakthrough Device

Aug 5, 2021

Bioprosthetic valve for chronic venous insufficiency nets

Bioprosthetic valve for chronic venous insufficiency nets

Aug 5, 2021

Hancock Jaffe’s Surgical VenoValve for Treating Chronic Venous Insufficiency Gains FDA Breakthrough Device Designation

Hancock Jaffe’s Surgical VenoValve for Treating Chronic Venous Insufficiency Gains FDA Breakthrough Device Designation

Aug 3, 2021

FDA grants Breakthrough Device designation

FDA grants Breakthrough Device designation

Aug 3, 2021

SVS advocacy efforts help spark landmark change in research effort requirements

SVS advocacy efforts help spark landmark change in research effort requirements

May 31, 2021

Show / Refresh / Reset / Delete

Views until show: 5
Seconds until show: 5